Prostaglandin E2 and misoprostol induce neurite retraction in Neuro-2a cells

Biochemical and Biophysical Research Communications

Volumn 398, Issue 3, 2010, Pages 450-456

  Tamiji, Javaneh ^a   Crawford, Dorota A ^a  

^a YORK UNIVERSITY   (Canada)

Author keywords

Autism; Calcium transients; Differentiation; Growth cone; Misoprostol; Prostaglandin E2 (PGE2)

Indexed keywords

MESSENGER RNA; MISOPROSTOL; PROSTAGLANDIN E2; PROSTANOID RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; GENE EXPRESSION; GROWTH CONE; LIPID PEROXIDATION; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEURITE; NEUROBLASTOMA CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; CALCIUM; CELL LINE, TUMOR; DINOPROSTONE; FLUORESCENT DYES; FURA-2; GROWTH CONES; MICE; MISOPROSTOL; NEURITES; NEUROGENESIS; RECEPTORS, PROSTAGLANDIN E; RNA, MESSENGER;

EID: 77955282361     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.098     Document Type: Article

References (41)

1. Breyer R.M., Bagdassarian C.K., Myers S.A., Breyer M.D. Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 2001, 41:661-690.
2. Hatae N., Sugimoto Y., Ichikawa A. Prostaglandin receptors: advances in the study of EP3 receptor signaling. J. Biochem. 2002, 131:781-784.
3. Lazarus M. The differential role of prostaglandin E2 receptors EP3 and EP4 in regulation of fever. Mol. Nutr. Food Res. 2006, 50:451-455.
4. Hata A.N., Breyer R.M. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol. Ther. 2004, 103:147-166.
5. Minami T., Nakano H., Kobayashi T., Sugimoto Y., Ushikubi F., Ichikawa A., Narumiya S., Ito S. Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice. Br. J. Pharmacol. 2001, 133:438-444.
6. Li D.Y., Varma D.R., Chatterjee T.K., Fernandez H., Abran D., Chemtob S. Fewer PGE2 and PGF2 alpha receptors in brain synaptosomes of newborn than of adult pigs. J. Pharmacol. Exp. Ther. 1993, 267:1292-1297.
7. Burks S.R., Wright C.L., McCarthy M.M. Exploration of prostanoid receptor subtype regulating estradiol and prostaglandin E2 induction of spinophilin in developing preoptic area neurons. Neuroscience 2007, 146:1117-1127.
8. Chen C., Magee J.C., Bazan N.G. Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity. J. Neurophysiol. 2002, 87:2851-2857.
9. Zhu P., Genc A., Zhang X., Zhang J., Bazan N.G., Chen C. Heterogeneous expression and regulation of hippocampal prostaglandin E2 receptors. J. Neurosci. Res. 2005, 81:817-826.
10. Katoh H., Aoki J., Ichikawa A., Negishi M. p160 RhoA-binding kinase ROKalpha induces neurite retraction. J. Biol. Chem. 1998, 273:2489-2492.
11. Katoh H., Negishi M., Ichikawa A. Prostaglandin E receptor EP3 subtype induces neurite retraction via small GTPase Rho. J. Biol. Chem. 1996, 271:29780-29784.
12. Al-Gadani Y., El-Ansary A., Attas O., Al-Ayadhi L. Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. Clin. Biochem. 2009, 42:1032-1040.
13. Mostafa G.A., El-Hadidi E.S., Hewedi D.H., Abdou M.M. Oxidative stress in Egyptian children with autism: relation to autoimmunity. J. Neuroimmunol. 2010, 219:114-118.
14. Miller M.T., Stromland K., Ventura L., Johansson M., Bandim J.M., Gillberg C. Autism associated with conditions characterized by developmental errors in early embryogenesis: a mini review. Int. J. Dev. Neurosci. 2005, 23:201-219.
15. Bandim J.M., Ventura L.O., Miller M.T., Almeida H.C., Costa A.E. Autism and Mobius sequence: an exploratory study of children in northeastern Brazil. Arq. Neuropsiquiatr. 2003, 61:181-185.
16. Abramovitz M., Adam M., Boie Y., Carriere M., Denis D., Godbout C., Lamontagne S., Rochette C., Sawyer N., Tremblay N.M., Belley M., Gallant M., Dufresne C., Gareau Y., Ruel R., Juteau H., Labelle M., Ouimet N., Metters K.M. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim. Biophys. Acta 2000, 1483:285-293.
17. Vallipuram J., Grenville J., Crawford D.A. The E646D-ATP13A4 mutation associated with autism reveals a defect in calcium regulation. Cell. Mol. Neurobiol. 2010, 30:233-246.
18. Aoki J., Katoh H., Yasui H., Yamaguchi Y., Nakamura K., Hasegawa H., Ichikawa A., Negishi M. Signal transduction pathway regulating prostaglandin EP3 receptor-induced neurite retraction: requirement for two different tyrosine kinases. Biochem. J. 1999, 340(Pt. 2):365-369.
19. Grynkiewicz G., Poenie M., Tsien R.Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260:3440-3450.
20. Santos A.R., Duarte C.B. Validation of internal control genes for expression studies: effects of the neurotrophin BDNF on hippocampal neurons. J. Neurosci. Res. 2008, 86:3684-3692.
21. Kater S.B., Mills L.R. Regulation of growth cone behavior by calcium. J. Neurosci. 1991, 11:891-899.
22. Hui K., Fei G.H., Saab B.J., Su J., Roder J.C., Feng Z.P. Neuronal calcium sensor-1 modulation of optimal calcium level for neurite outgrowth. Development 2007, 134:4479-4489.
23. Gomez T.M., Snow D.M., Letourneau P.C. Characterization of spontaneous calcium transients in nerve growth cones and their effect on growth cone migration. Neuron 1995, 14:1233-1246.
24. Lipscombe D., Madison D.V., Poenie M., Reuter H., Tsien R.Y., Tsien R.W. Spatial distribution of calcium channels and cytosolic calcium transients in growth cones and cell bodies of sympathetic neurons. Proc. Natl. Acad. Sci. USA 1988, 85:2398-2402.
25. Gomez T.M., Spitzer N.C. In vivo regulation of axon extension and pathfinding by growth-cone calcium transients. Nature 1999, 397:350-355.
26. Bilson H.A., Mitchell D.L., Ashby B. Human prostaglandin EP3 receptor isoforms show different agonist-induced internalization patterns. FEBS Lett. 2004, 572:271-275.
27. Nishigaki N., Negishi M., Ichikawa A. Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist. Mol. Pharmacol. 1996, 50:1031-1037.
28. Gomez T.M., Robles E., Poo M., Spitzer N.C. Filopodial calcium transients promote substrate-dependent growth cone turning. Science 2001, 291:1983-1987.
29. Wise H. Lack of interaction between prostaglandin E2 receptor subtypes in regulating adenylyl cyclase activity in cultured rat dorsal root ganglion cells. Eur. J. Pharmacol. 2006, 535:69-77.
30. Fagerstrom S., Pahlman S., Gestblom C., Nanberg E. Protein kinase C-epsilon is implicated in neurite outgrowth in differentiating human neuroblastoma cells. Cell Growth Differ. 1996, 7:775-785.
31. Marty V., El Hachmane M., Amedee T. Dual modulation of synaptic transmission in the nucleus tractus solitarius by prostaglandin E2 synthesized downstream of IL-1beta. Eur. J. Neurosci. 2008, 27:3132-3150.
32. Yang H., Chen C. Cyclooxygenase-2 in synaptic signaling. Curr. Pharm. Des. 2008, 14:1443-1451.
33. Smith H.S. Arachidonic acid pathways in nociception. J. Support. Oncol. 2006, 4:277-287.
34. Pepicelli O., Fedele E., Berardi M., Raiteri M., Levi G., Greco A., Ajmone-Cat M.A., Minghetti L. Cyclo-oxygenase-1 and -2 differently contribute to prostaglandin E2 synthesis and lipid peroxidation after in vivo activation of N-methyl-d-aspartate receptors in rat hippocampus. J. Neurochem. 2005, 93:1561-1567.
35. Benvenuto A., Manzi B., Alessandrelli R., Galasso C., Curatolo P. Recent advances in the pathogenesis of syndromic autisms. Int. J. Pediatr. 2009, 2009:198736.
36. Mora M., Quintero L., Cardenas R., Suarez-Roca H., Zavala M., Montiel N. Association between HSV-2 infection and serum anti-rat brain antibodies in patients with autism. Invest. Clin. 2009, 50:315-326.
37. Fatemi S.H., Earle J., Kanodia R., Kist D., Emamian E.S., Patterson P.H., Shi L., Sidwell R. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell. Mol. Neurobiol. 2002, 22:25-33.
38. Rice D., Barone S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Perspect. 2000, 108(Suppl. 3):511-533.
39. Nakamura K., Li Y.Q., Kaneko T., Katoh H., Negishi M. Prostaglandin EP3 receptor protein in serotonin and catecholamine cell groups: a double immunofluorescence study in the rat brain. Neuroscience 2001, 103:763-775.
40. Dufour-Rainfray D., Vourc'h P., Le Guisquet A.M., Garreau L., Ternant D., Bodard S., Jaumain E., Gulhan Z., Belzung C., Andres C.R., Chalon S., Guilloteau D. Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism. Neurosci. Lett. 2010, 470:55-59.
41. Zafeiriou D.I., Ververi A., Vargiami E. The serotonergic system: its role in pathogenesis and early developmental treatment of autism. Curr. Neuropharmacol. 2009, 7:150-157.